Categories AlphaGraphs, Earnings, Technology

Earnings: Highlights of International Business Machines’ (IBM) Q1 results

International Business Machines Corporation (NYSE: IBM) announced operating results for the first quarter, reporting a decline in adjusted earnings.

International Business Machines Q1 2023 earnings infographic

Total revenues were $14.3 billion in the first three months of fiscal 2023, which is broadly unchanged from the prior-year period. Meanwhile, adjusted earnings from continuing operations declined to $1.36 per share from $1.40 per share in the year-ago period. On an unadjusted basis, March-quarter net profit was $927 million or $1.01 per share, compared to $733 million or $0.81 per share in the corresponding period of 2022.

“Our first quarter results demonstrate that clients continue turning to IBM for our unique combination of an open hybrid cloud platform, enterprise-focused AI, and business expertise to unlock productivity and drive efficiency in their operations,” said IBM’s CEO Arvind Krishna.

Prior Performance

  • International Business Machines Q4 2022 earnings infographic
  • IBM Q3 2022 earnings infographic
  • IBM Q4 2021 earnings infographic


Stocks you may like:

Apple (AAPL) Stock

Microsoft (MSFT) Stock

Alphabet (GOOGL) Stock

International Business Machines Corp. (IBM) Stock


Most Popular

BLK Earnings: BlackRock Q2 2024 profit jumps on higher revenues

Asset management company BlackRock, Inc. (NYSE: BLK) on Monday reported a double-digit increase in adjusted profit for the second quarter of 2024, aided by an 8% increase in revenues. Second-quarter

GS Earnings: All you need to know about Goldman Sachs’ Q2 2024 earnings results

The Goldman Sachs Group, Inc. (NYSE: GS) reported its second quarter 2024 earnings results today. Net revenues were $12.73 billion, up 17% compared to the same period a year ago,

Intuitive Surgical likely to report strong revenue, profit growth for Q2 2024

Intuitive Surgical, Inc. (NASDAQ: ISRG) is expected to report its second-quarter earnings next week, amid expectations for strong revenue and profit growth. The medical device maker is thriving on the

Add Comment
Viewing Highlight